BIOMAT Database Logo BIOMAT Database Logo

[Thrombolytic therapy in acute myocardial infarct]. 1992

C Bode, and H Baumann, and E von Hodenberg, and W Kübler
Medizinische Klinik III (Kardiologie, Pulmologie und Angiologie), Universität Heidelberg.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012770 Shock, Cardiogenic Shock resulting from diminution of cardiac output in heart disease. Cardiogenic Shock
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
April 1990, Recenti progressi in medicina,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
January 1998, Bratislavske lekarske listy,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
May 1985, Deutsche medizinische Wochenschrift (1946),
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
September 1987, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
April 1990, Casopis lekaru ceskych,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
December 2002, Hamostaseologie,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy in acute myocardial infarct].
May 1992, La Clinica terapeutica,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy of acute myocardial infarct].
August 1993, Bratislavske lekarske listy,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy of acute myocardial infarct].
November 1972, Minerva cardioangiologica,
C Bode, and H Baumann, and E von Hodenberg, and W Kübler
[Thrombolytic therapy for acute myocardial infarct].
May 2001, Der Internist,
Copied contents to your clipboard!